News | Quality Assurance (QA) | June 07, 2019

IBA Dosimetry Launches myQA iON

Quality assurance software will shorten patient QA time by a factor of three by integrating log file QA, Monte Carlo calculation and workflow streamlining

IBA Dosimetry Launches myQA iON

June 7, 2019 — IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (PTCOG) conference, June 10-15 in Manchester, U.K. The company said myQA iON significantly reduces the time needed for patient quality assurance (QA) for proton therapy (PT).

The use of PT machine log files, process automation, task-based workflows and the latest web technologies in myQA iON significantly increase QA efficiency while ensuring patient treatment safety. Compared to conventional detector measurements (at isocenter), myQA iON enables a reduction of the QA measurement effort that results in a three times faster patient QA. This efficiency increase was confirmed by a global survey conducted amongst 37 practicing medical physicists at proton therapy centers.

“Combining irradiation logs and an independent dose recalculation with myQA iON, we intend to reduce the amount of measurements performed for patient QA by approximately 90 percent,” said Stefan Both, professor and head of medical physics at the Department of Radiation Oncology, University Medical Center Groningen, Netherlands.

myQA iON combines the analysis of irradiation log files and sophisticated high-accuracy Monte Carlo dose recalculation to provide the user with an independent QA dose calculation, as well as the ability to verify the quality and safety of each patient treatment fraction.

“The ability to automate our patient QA, and the flexibility to use irradiation log files, real dose measurements and Monte Carlo secondary recalculations in one system will bring us to a new level in PT treatment plan QA efficiency and accuracy,” said Zuofeng Li, physics director at the University of Florida Health Proton Therapy Institute, Jacksonville, Fla.

The software environment offers all patient QA tasks and workflow steps in a single interface. The latest web technologies allow users to access their patient QA anytime and anywhere within the hospital network. myQA iON supports patient QA for proton therapy machines of all major vendors.

myQA iON is currently undergoing U.S. Food and Drug Administration (FDA) 510(k) review.

For more information: www.iba-worldwide.com

Related Content

Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

News | Quality Assurance (QA) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning

The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning. Image courtesy of Siemens Healthineers.

News | Computed Tomography (CT) | September 15, 2019
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the...
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the...
Akesis Galaxy SRS System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | September 13, 2019
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has...
Philips Showcases Integrated Radiation Oncology Portfolio at ASTRO 2019
News | Radiation Oncology | September 13, 2019
Philips will showcase its integrated radiation oncology portfolio at the American Society of Radiation Oncology (ASTRO...
RefleXion Highlights Novel Approach to Radiotherapy at ASTRO 2019

The RefleXion X1 Machine without the Gantry Cover. The patented technology incorporates PET imaging data, which enables tumors to continuously signal their location. Image courtesy of Reflexion Medical.

News | Radiation Therapy | September 12, 2019
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American...
IBA Dosimetry Releases myQA Machines Software at ASTRO 2019
Technology | Quality Assurance (QA) | September 12, 2019
IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming...
ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
News | Image Guided Radiation Therapy (IGRT) | September 11, 2019
ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation...